Sunesis (SNSS) Catches Eye: Stock Soars 18.3% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Sunesis Pharmaceuticals, Inc. ( SNSS ) was a big mover last session with its shares surging over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend as the stock lost over 12% between Jan 17 and Feb 6.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't remained in trend either. Friday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sunesis currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked biomedical stocks include Actelion Ltd. ( ALIOF ), Gentium S.p.A ( GENT ) and Cambrex Corp. ( CBM ). All these stocks bear a Zacks Rank #1 (Strong Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


CAMBREX CORP (CBM): Free Stock Analysis Report

GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

SUNESIS PHARMA (SNSS): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: ALIOF , CBM , GENT , SNSS

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by